 | • レポートコード：GIR-107A11913 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、幹細胞治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。幹細胞治療の種類別市場規模（脂肪組織由来間葉系幹細胞、骨髄由来間葉系幹細胞、臍帯血/胚性幹細胞、その他）、用途別市場規模（神経疾患、免疫疾患、筋骨格系障害、心血管疾患、胃腸疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・幹細胞治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Osiris Therapeutics, Inc、MEDIPOST Co., Ltd、JCR Pharmaceuticals Co., Ltd、FUJIFILM Cellular Dynamics, Inc.、Holostem Terapie Avanzate S.r.l.、Athersys Inc.、CORESTEM, Inc、Mesoblast Ltd.、Regenexx、Reliance Life Sciences Private Limited、U.S. Stem Cell, Inc.、Vericel Corporation、Pharmicell Co., Ltd ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：脂肪組織由来間葉系幹細胞、骨髄由来間葉系幹細胞、臍帯血/胚性幹細胞、その他 ・用途別分析2016年-2026年：神経疾患、免疫疾患、筋骨格系障害、心血管疾患、胃腸疾患、その他 ・幹細胞治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・幹細胞治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・幹細胞治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・幹細胞治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・幹細胞治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Stem Cell Treatments market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Stem Cell Treatments size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Stem Cell Treatments market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Stem Cell Treatments market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Adipose Tissue-Derived Mesenchymal Stem Cells
Bone Marrow-Derived Mesenchymal Stem Cells
Cord Blood/Embryonic Stem Cells
Other Cell Sources
Market segment by Application, can be divided into
Nerve Diseases
Immunological Diseases
Musculoskeletal Disorders
Cardiovascular Diseases
Gastrointestinal Diseases
Other
Market segment by players, this report covers
Osiris Therapeutics, Inc
MEDIPOST Co., Ltd
JCR Pharmaceuticals Co., Ltd
FUJIFILM Cellular Dynamics, Inc.
Holostem Terapie Avanzate S.r.l.
Athersys Inc.
CORESTEM, Inc
Mesoblast Ltd.
Regenexx
Reliance Life Sciences Private Limited
U.S. Stem Cell, Inc.
Vericel Corporation
Pharmicell Co., Ltd
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Stem Cell Treatments
1.2 Classification of Stem Cell Treatments by Type
1.2.1 Overview: Global Stem Cell Treatments Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Stem Cell Treatments Revenue Market Share by Type in 2020
1.2.3 Adipose Tissue-Derived Mesenchymal Stem Cells
1.2.4 Bone Marrow-Derived Mesenchymal Stem Cells
1.2.5 Cord Blood/Embryonic Stem Cells
1.2.6 Other Cell Sources
1.3 Global Stem Cell Treatments Market by Application
1.3.1 Overview: Global Stem Cell Treatments Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Nerve Diseases
1.3.3 Immunological Diseases
1.3.4 Musculoskeletal Disorders
1.3.5 Cardiovascular Diseases
1.3.6 Gastrointestinal Diseases
1.3.7 Other
1.4 Global Stem Cell Treatments Market Size & Forecast
1.5 Global Stem Cell Treatments Market Size and Forecast by Region
1.5.1 Global Stem Cell Treatments Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Stem Cell Treatments Market Size by Region, (2016-2021)
1.5.3 North America Stem Cell Treatments Market Size and Prospect (2016-2026)
1.5.4 Europe Stem Cell Treatments Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Stem Cell Treatments Market Size and Prospect (2016-2026)
1.5.6 South America Stem Cell Treatments Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Stem Cell Treatments Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Stem Cell Treatments Market Drivers
1.6.2 Stem Cell Treatments Market Restraints
1.6.3 Stem Cell Treatments Trends Analysis
2 Company Profiles
2.1 Osiris Therapeutics, Inc
2.1.1 Osiris Therapeutics, Inc Details
2.1.2 Osiris Therapeutics, Inc Major Business
2.1.3 Osiris Therapeutics, Inc Stem Cell Treatments Product and Solutions
2.1.4 Osiris Therapeutics, Inc Stem Cell Treatments Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Osiris Therapeutics, Inc Recent Developments and Future Plans
2.2 MEDIPOST Co., Ltd
2.2.1 MEDIPOST Co., Ltd Details
2.2.2 MEDIPOST Co., Ltd Major Business
2.2.3 MEDIPOST Co., Ltd Stem Cell Treatments Product and Solutions
2.2.4 MEDIPOST Co., Ltd Stem Cell Treatments Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 MEDIPOST Co., Ltd Recent Developments and Future Plans
2.3 JCR Pharmaceuticals Co., Ltd
2.3.1 JCR Pharmaceuticals Co., Ltd Details
2.3.2 JCR Pharmaceuticals Co., Ltd Major Business
2.3.3 JCR Pharmaceuticals Co., Ltd Stem Cell Treatments Product and Solutions
2.3.4 JCR Pharmaceuticals Co., Ltd Stem Cell Treatments Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 JCR Pharmaceuticals Co., Ltd Recent Developments and Future Plans
2.4 FUJIFILM Cellular Dynamics, Inc.
2.4.1 FUJIFILM Cellular Dynamics, Inc. Details
2.4.2 FUJIFILM Cellular Dynamics, Inc. Major Business
2.4.3 FUJIFILM Cellular Dynamics, Inc. Stem Cell Treatments Product and Solutions
2.4.4 FUJIFILM Cellular Dynamics, Inc. Stem Cell Treatments Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 FUJIFILM Cellular Dynamics, Inc. Recent Developments and Future Plans
2.5 Holostem Terapie Avanzate S.r.l.
2.5.1 Holostem Terapie Avanzate S.r.l. Details
2.5.2 Holostem Terapie Avanzate S.r.l. Major Business
2.5.3 Holostem Terapie Avanzate S.r.l. Stem Cell Treatments Product and Solutions
2.5.4 Holostem Terapie Avanzate S.r.l. Stem Cell Treatments Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Holostem Terapie Avanzate S.r.l. Recent Developments and Future Plans
2.6 Athersys Inc.
2.6.1 Athersys Inc. Details
2.6.2 Athersys Inc. Major Business
2.6.3 Athersys Inc. Stem Cell Treatments Product and Solutions
2.6.4 Athersys Inc. Stem Cell Treatments Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Athersys Inc. Recent Developments and Future Plans
2.7 CORESTEM, Inc
2.7.1 CORESTEM, Inc Details
2.7.2 CORESTEM, Inc Major Business
2.7.3 CORESTEM, Inc Stem Cell Treatments Product and Solutions
2.7.4 CORESTEM, Inc Stem Cell Treatments Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 CORESTEM, Inc Recent Developments and Future Plans
2.8 Mesoblast Ltd.
2.8.1 Mesoblast Ltd. Details
2.8.2 Mesoblast Ltd. Major Business
2.8.3 Mesoblast Ltd. Stem Cell Treatments Product and Solutions
2.8.4 Mesoblast Ltd. Stem Cell Treatments Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Mesoblast Ltd. Recent Developments and Future Plans
2.9 Regenexx
2.9.1 Regenexx Details
2.9.2 Regenexx Major Business
2.9.3 Regenexx Stem Cell Treatments Product and Solutions
2.9.4 Regenexx Stem Cell Treatments Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Regenexx Recent Developments and Future Plans
2.10 Reliance Life Sciences Private Limited
2.10.1 Reliance Life Sciences Private Limited Details
2.10.2 Reliance Life Sciences Private Limited Major Business
2.10.3 Reliance Life Sciences Private Limited Stem Cell Treatments Product and Solutions
2.10.4 Reliance Life Sciences Private Limited Stem Cell Treatments Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Reliance Life Sciences Private Limited Recent Developments and Future Plans
2.11 U.S. Stem Cell, Inc.
2.11.1 U.S. Stem Cell, Inc. Details
2.11.2 U.S. Stem Cell, Inc. Major Business
2.11.3 U.S. Stem Cell, Inc. Stem Cell Treatments Product and Solutions
2.11.4 U.S. Stem Cell, Inc. Stem Cell Treatments Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 U.S. Stem Cell, Inc. Recent Developments and Future Plans
2.12 Vericel Corporation
2.12.1 Vericel Corporation Details
2.12.2 Vericel Corporation Major Business
2.12.3 Vericel Corporation Stem Cell Treatments Product and Solutions
2.12.4 Vericel Corporation Stem Cell Treatments Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Vericel Corporation Recent Developments and Future Plans
2.13 Pharmicell Co., Ltd
2.13.1 Pharmicell Co., Ltd Details
2.13.2 Pharmicell Co., Ltd Major Business
2.13.3 Pharmicell Co., Ltd Stem Cell Treatments Product and Solutions
2.13.4 Pharmicell Co., Ltd Stem Cell Treatments Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Pharmicell Co., Ltd Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Stem Cell Treatments Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Stem Cell Treatments Players Market Share
3.2.2 Top 10 Stem Cell Treatments Players Market Share
3.2.3 Market Competition Trend
3.3 Stem Cell Treatments Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Stem Cell Treatments Revenue and Market Share by Type (2016-2021)
4.2 Global Stem Cell Treatments Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Stem Cell Treatments Revenue Market Share by Application (2016-2021)
5.2 Stem Cell Treatments Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Stem Cell Treatments Revenue by Type (2016-2026)
6.2 North America Stem Cell Treatments Revenue by Application (2016-2026)
6.3 North America Stem Cell Treatments Market Size by Country
6.3.1 North America Stem Cell Treatments Revenue by Country (2016-2026)
6.3.2 United States Stem Cell Treatments Market Size and Forecast (2016-2026)
6.3.3 Canada Stem Cell Treatments Market Size and Forecast (2016-2026)
6.3.4 Mexico Stem Cell Treatments Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Stem Cell Treatments Revenue by Type (2016-2026)
7.2 Europe Stem Cell Treatments Revenue by Application (2016-2026)
7.3 Europe Stem Cell Treatments Market Size by Country
7.3.1 Europe Stem Cell Treatments Revenue by Country (2016-2026)
7.3.2 Germany Stem Cell Treatments Market Size and Forecast (2016-2026)
7.3.3 France Stem Cell Treatments Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Stem Cell Treatments Market Size and Forecast (2016-2026)
7.3.5 Russia Stem Cell Treatments Market Size and Forecast (2016-2026)
7.3.6 Italy Stem Cell Treatments Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Stem Cell Treatments Revenue by Type (2016-2026)
8.2 Asia-Pacific Stem Cell Treatments Revenue by Application (2016-2026)
8.3 Asia-Pacific Stem Cell Treatments Market Size by Region
8.3.1 Asia-Pacific Stem Cell Treatments Revenue by Region (2016-2026)
8.3.2 China Stem Cell Treatments Market Size and Forecast (2016-2026)
8.3.3 Japan Stem Cell Treatments Market Size and Forecast (2016-2026)
8.3.4 South Korea Stem Cell Treatments Market Size and Forecast (2016-2026)
8.3.5 India Stem Cell Treatments Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Stem Cell Treatments Market Size and Forecast (2016-2026)
8.3.7 Australia Stem Cell Treatments Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Stem Cell Treatments Revenue by Type (2016-2026)
9.2 South America Stem Cell Treatments Revenue by Application (2016-2026)
9.3 South America Stem Cell Treatments Market Size by Country
9.3.1 South America Stem Cell Treatments Revenue by Country (2016-2026)
9.3.2 Brazil Stem Cell Treatments Market Size and Forecast (2016-2026)
9.3.3 Argentina Stem Cell Treatments Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Stem Cell Treatments Revenue by Type (2016-2026)
10.2 Middle East & Africa Stem Cell Treatments Revenue by Application (2016-2026)
10.3 Middle East & Africa Stem Cell Treatments Market Size by Country
10.3.1 Middle East & Africa Stem Cell Treatments Revenue by Country (2016-2026)
10.3.2 Turkey Stem Cell Treatments Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Stem Cell Treatments Market Size and Forecast (2016-2026)
10.3.4 UAE Stem Cell Treatments Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Stem Cell Treatments Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Stem Cell Treatments Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Stem Cell Treatments Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Stem Cell Treatments Revenue (USD Million) by Region (2016-2021)
Table 5. Global Stem Cell Treatments Revenue Market Share by Region (2021-2026)
Table 6. Osiris Therapeutics, Inc Corporate Information, Head Office, and Major Competitors
Table 7. Osiris Therapeutics, Inc Major Business
Table 8. Osiris Therapeutics, Inc Stem Cell Treatments Product and Solutions
Table 9. Osiris Therapeutics, Inc Stem Cell Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. MEDIPOST Co., Ltd Corporate Information, Head Office, and Major Competitors
Table 11. MEDIPOST Co., Ltd Major Business
Table 12. MEDIPOST Co., Ltd Stem Cell Treatments Product and Solutions
Table 13. MEDIPOST Co., Ltd Stem Cell Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. JCR Pharmaceuticals Co., Ltd Corporate Information, Head Office, and Major Competitors
Table 15. JCR Pharmaceuticals Co., Ltd Major Business
Table 16. JCR Pharmaceuticals Co., Ltd Stem Cell Treatments Product and Solutions
Table 17. JCR Pharmaceuticals Co., Ltd Stem Cell Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. FUJIFILM Cellular Dynamics, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. FUJIFILM Cellular Dynamics, Inc. Major Business
Table 20. FUJIFILM Cellular Dynamics, Inc. Stem Cell Treatments Product and Solutions
Table 21. FUJIFILM Cellular Dynamics, Inc. Stem Cell Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Holostem Terapie Avanzate S.r.l. Corporate Information, Head Office, and Major Competitors
Table 23. Holostem Terapie Avanzate S.r.l. Major Business
Table 24. Holostem Terapie Avanzate S.r.l. Stem Cell Treatments Product and Solutions
Table 25. Holostem Terapie Avanzate S.r.l. Stem Cell Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Athersys Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Athersys Inc. Major Business
Table 28. Athersys Inc. Stem Cell Treatments Product and Solutions
Table 29. Athersys Inc. Stem Cell Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. CORESTEM, Inc Corporate Information, Head Office, and Major Competitors
Table 31. CORESTEM, Inc Major Business
Table 32. CORESTEM, Inc Stem Cell Treatments Product and Solutions
Table 33. CORESTEM, Inc Stem Cell Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Mesoblast Ltd. Corporate Information, Head Office, and Major Competitors
Table 35. Mesoblast Ltd. Major Business
Table 36. Mesoblast Ltd. Stem Cell Treatments Product and Solutions
Table 37. Mesoblast Ltd. Stem Cell Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Regenexx Corporate Information, Head Office, and Major Competitors
Table 39. Regenexx Major Business
Table 40. Regenexx Stem Cell Treatments Product and Solutions
Table 41. Regenexx Stem Cell Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Reliance Life Sciences Private Limited Corporate Information, Head Office, and Major Competitors
Table 43. Reliance Life Sciences Private Limited Major Business
Table 44. Reliance Life Sciences Private Limited Stem Cell Treatments Product and Solutions
Table 45. Reliance Life Sciences Private Limited Stem Cell Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. U.S. Stem Cell, Inc. Corporate Information, Head Office, and Major Competitors
Table 47. U.S. Stem Cell, Inc. Major Business
Table 48. U.S. Stem Cell, Inc. Stem Cell Treatments Product and Solutions
Table 49. U.S. Stem Cell, Inc. Stem Cell Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Vericel Corporation Corporate Information, Head Office, and Major Competitors
Table 51. Vericel Corporation Major Business
Table 52. Vericel Corporation Stem Cell Treatments Product and Solutions
Table 53. Vericel Corporation Stem Cell Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Pharmicell Co., Ltd Corporate Information, Head Office, and Major Competitors
Table 55. Pharmicell Co., Ltd Major Business
Table 56. Pharmicell Co., Ltd Stem Cell Treatments Product and Solutions
Table 57. Pharmicell Co., Ltd Stem Cell Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global Stem Cell Treatments Revenue (USD Million) by Players (2019-2021)
Table 59. Global Stem Cell Treatments Revenue Share by Players (2019-2021)
Table 60. Breakdown of Stem Cell Treatments by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Stem Cell Treatments Players Head Office, Products and Services Provided
Table 62. Stem Cell Treatments Mergers & Acquisitions in the Past Five Years
Table 63. Stem Cell Treatments New Entrants and Expansion Plans
Table 64. Global Stem Cell Treatments Revenue (USD Million) by Type (2016-2021)
Table 65. Global Stem Cell Treatments Revenue Share by Type (2016-2021)
Table 66. Global Stem Cell Treatments Revenue Forecast by Type (2021-2026)
Table 67. Global Stem Cell Treatments Revenue by Application (2016-2021)
Table 68. Global Stem Cell Treatments Revenue Forecast by Application (2021-2026)
Table 69. North America Stem Cell Treatments Revenue by Type (2016-2021) & (USD Million)
Table 70. North America Stem Cell Treatments Revenue by Type (2021-2026) & (USD Million)
Table 71. North America Stem Cell Treatments Revenue by Application (2016-2021) & (USD Million)
Table 72. North America Stem Cell Treatments Revenue by Application (2021-2026) & (USD Million)
Table 73. North America Stem Cell Treatments Revenue by Country (2016-2021) & (USD Million)
Table 74. North America Stem Cell Treatments Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe Stem Cell Treatments Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe Stem Cell Treatments Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe Stem Cell Treatments Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe Stem Cell Treatments Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe Stem Cell Treatments Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe Stem Cell Treatments Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific Stem Cell Treatments Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific Stem Cell Treatments Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Stem Cell Treatments Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific Stem Cell Treatments Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Stem Cell Treatments Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific Stem Cell Treatments Revenue by Region (2021-2026) & (USD Million)
Table 87. South America Stem Cell Treatments Revenue by Type (2016-2021) & (USD Million)
Table 88. South America Stem Cell Treatments Revenue by Type (2021-2026) & (USD Million)
Table 89. South America Stem Cell Treatments Revenue by Application (2016-2021) & (USD Million)
Table 90. South America Stem Cell Treatments Revenue by Application (2021-2026) & (USD Million)
Table 91. South America Stem Cell Treatments Revenue by Country (2016-2021) & (USD Million)
Table 92. South America Stem Cell Treatments Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa Stem Cell Treatments Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa Stem Cell Treatments Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Stem Cell Treatments Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa Stem Cell Treatments Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Stem Cell Treatments Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa Stem Cell Treatments Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Stem Cell Treatments Picture
Figure 2. Global Stem Cell Treatments Revenue Market Share by Type in 2020
Figure 3. Adipose Tissue-Derived Mesenchymal Stem Cells
Figure 4. Bone Marrow-Derived Mesenchymal Stem Cells
Figure 5. Cord Blood/Embryonic Stem Cells
Figure 6. Other Cell Sources
Figure 7. Stem Cell Treatments Revenue Market Share by Application in 2020
Figure 8. Nerve Diseases Picture
Figure 9. Immunological Diseases Picture
Figure 10. Musculoskeletal Disorders Picture
Figure 11. Cardiovascular Diseases Picture
Figure 12. Gastrointestinal Diseases Picture
Figure 13. Other Picture
Figure 14. Global Stem Cell Treatments Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 15. Global Stem Cell Treatments Revenue and Forecast (2016-2026) & (USD Million)
Figure 16. Global Stem Cell Treatments Revenue Market Share by Region (2016-2026)
Figure 17. Global Stem Cell Treatments Revenue Market Share by Region in 2020
Figure 18. North America Stem Cell Treatments Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Europe Stem Cell Treatments Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Asia-Pacific Stem Cell Treatments Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. South America Stem Cell Treatments Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Middle East and Africa Stem Cell Treatments Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Stem Cell Treatments Market Drivers
Figure 24. Stem Cell Treatments Market Restraints
Figure 25. Stem Cell Treatments Market Trends
Figure 26. Osiris Therapeutics, Inc Recent Developments and Future Plans
Figure 27. MEDIPOST Co., Ltd Recent Developments and Future Plans
Figure 28. JCR Pharmaceuticals Co., Ltd Recent Developments and Future Plans
Figure 29. FUJIFILM Cellular Dynamics, Inc. Recent Developments and Future Plans
Figure 30. Holostem Terapie Avanzate S.r.l. Recent Developments and Future Plans
Figure 31. Athersys Inc. Recent Developments and Future Plans
Figure 32. CORESTEM, Inc Recent Developments and Future Plans
Figure 33. Mesoblast Ltd. Recent Developments and Future Plans
Figure 34. Regenexx Recent Developments and Future Plans
Figure 35. Reliance Life Sciences Private Limited Recent Developments and Future Plans
Figure 36. U.S. Stem Cell, Inc. Recent Developments and Future Plans
Figure 37. Vericel Corporation Recent Developments and Future Plans
Figure 38. Pharmicell Co., Ltd Recent Developments and Future Plans
Figure 39. Global Stem Cell Treatments Revenue Share by Players in 2020
Figure 40. Stem Cell Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 41. Global Top 3 Players Stem Cell Treatments Revenue Market Share in 2020
Figure 42. Global Top 10 Players Stem Cell Treatments Revenue Market Share in 2020
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 44. Global Stem Cell Treatments Revenue Share by Type in 2020
Figure 45. Global Stem Cell Treatments Market Share Forecast by Type (2021-2026)
Figure 46. Global Stem Cell Treatments Revenue Share by Application in 2020
Figure 47. Global Stem Cell Treatments Market Share Forecast by Application (2021-2026)
Figure 48. North America Stem Cell Treatments Sales Market Share by Type (2016-2026)
Figure 49. North America Stem Cell Treatments Sales Market Share by Application (2016-2026)
Figure 50. North America Stem Cell Treatments Revenue Market Share by Country (2016-2026)
Figure 51. United States Stem Cell Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Canada Stem Cell Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Mexico Stem Cell Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Europe Stem Cell Treatments Sales Market Share by Type (2016-2026)
Figure 55. Europe Stem Cell Treatments Sales Market Share by Application (2016-2026)
Figure 56. Europe Stem Cell Treatments Revenue Market Share by Country (2016-2026)
Figure 57. Germany Stem Cell Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. France Stem Cell Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. United Kingdom Stem Cell Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Russia Stem Cell Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Italy Stem Cell Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Asia-Pacific Stem Cell Treatments Sales Market Share by Type (2016-2026)
Figure 63. Asia-Pacific Stem Cell Treatments Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Stem Cell Treatments Revenue Market Share by Region (2016-2026)
Figure 65. China Stem Cell Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Japan Stem Cell Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South Korea Stem Cell Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. India Stem Cell Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Southeast Asia Stem Cell Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Australia Stem Cell Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. South America Stem Cell Treatments Sales Market Share by Type (2016-2026)
Figure 72. South America Stem Cell Treatments Sales Market Share by Application (2016-2026)
Figure 73. South America Stem Cell Treatments Revenue Market Share by Country (2016-2026)
Figure 74. Brazil Stem Cell Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Argentina Stem Cell Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Middle East and Africa Stem Cell Treatments Sales Market Share by Type (2016-2026)
Figure 77. Middle East and Africa Stem Cell Treatments Sales Market Share by Application (2016-2026)
Figure 78. Middle East and Africa Stem Cell Treatments Revenue Market Share by Country (2016-2026)
Figure 79. Turkey Stem Cell Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia Stem Cell Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. UAE Stem Cell Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source
世界のヒト間葉系幹細胞（hMSC）市場 2021：企業別、地域別、種類・用途別 The Human Mesenchymal Stem Cells (hMSC) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…- 世界の自己幹細胞治療市場 2021：企業別、地域別、種類・用途別 The Autologous Stem Cell Based Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 世界の幹細胞用装置市場 2021：企業別、地域別、種類・用途別 The Stem Cell Equipment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界の成体幹細胞アッセイ市場 2021：企業別、地域別、種類・用途別 The Adult Stem Cell Assay market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界の幹細胞＆初代細胞培養培地市場 2021：企業別、地域別、種類・用途別 The Stem Cell and Primary Cell Culture Medium market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…